Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: systematic review and meta-analysis

…, M Le Maitre, S Aractingi, F Aubin, A Cantagrel… - Journal of the American …, 2015 - Elsevier
Background Skin psoriasis precedes the onset of psoriatic arthritis (PsA) in 84% of patients
with psoriasis. Dermatologists have an important role to screen psoriasis patients for PsA. …

Lumbar and cervical stenosis. Frequency of the association, role of the ankylosing hyperostosis

…, J Arlet, P Arrue, H Rousseau, A Cantagrel… - Clinical …, 1992 - Springer
The authors report a study of 47 patients admitted for cervical myelopathy (N=17) or
symptomatic lumbar spinal stenosis (N=30). Nine patients had clinical evidence of coexisting …

Actualisation des Recommandations de la Société française de rhumatologie pour la prise en charge de la polyarthrite rhumatoïde

C Daien, C Hua, C Gaujoux-Viala, A Cantagrel… - Revue du …, 2019 - Elsevier
Les précédentes recommandations de 2014 ont été actualisées par un groupe de travail
constitué de 12 experts rhumatologues, deux représentants des associations de patients et un …

Targeting monocytes/macrophages in the treatment of rheumatoid arthritis

…, F Apparailly, R Poupot, A Cantagrel - …, 2013 - academic.oup.com
Biotherapies have revolutionized the treatment of RA. However, much work is needed to
understand all the mechanisms of these biotherapies, and alternatives are needed to …

[HTML][HTML] Recommandations de la Société française de rhumatologie pour la prise en charge de la polyarthrite rhumatoïde

C Gaujoux-Viala, L Gossec, A Cantagrel… - Revue du …, 2014 - Elsevier
Cet article présente les recommandations de la Société française de rhumatologie pour la
prise en charge de la polyarthrite rhumatoïde (PR). Ces recommandations ont été élaborées …

Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis

JF Boyer, PA Gourraud, A Cantagrel, JL Davignon… - Joint Bone Spine, 2011 - Elsevier
OBJECTIVE: Rheumatoid arthritis is associated with increased cardiovascular morbidity and
mortality. We performed a systematic review of the literature and a meta-analysis to look for …

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week …

…, GR Burmester, P Cagnoli, PH Caldron, A Cantagrel… - The Lancet, 2017 - thelancet.com
Background Patients who have had inadequate response to tumour necrosis factor inhibitors
have fewer treatment options and are generally more treatment refractory to subsequent …

Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage

…, M Dougados, P Goupille, A Cantagrel… - Annals of the …, 2003 - ard.bmj.com
Objective: To study the value of antibodies to citrullinated proteins/peptides for predicting
joint outcomes in patients with recent onset rheumatoid arthritis (RA). Methods: 191 patients …

Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French autoimmunity and rituximab registry

…, C Bonnet, P Cacoub, A Cantagrel… - Arthritis & …, 2010 - Wiley Online Library
Objective A number of open‐label studies have suggested the potential benefit of rituximab (RTX)
in systemic lupus erythematosus (SLE). However, in 2 recent randomized controlled …

Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry

…, T Bardin, P Cacoub, A Cantagrel… - Arthritis & …, 2010 - Wiley Online Library
Objective The risk of severe infection is a crucial factor in the assessment of the short‐term
risk:benefit ratio of biologic drugs in rheumatoid arthritis (RA). There is no increase in severe …